J. Arrago

发表

SYSTEMIC EVALUATION OF SJÖGREN‐LIKE SYNDROME AFTER BONE MARROW TRANSPLANTATION IN MAN

E. Gluckman, A. Devergie, C. Brocheriou, 1987, Transplantation.

Scintigraphy of the salivary glands in Sjögen's syndrome.

F. Rocher, C. Brocheriou, J. Rain, 1987, Journal of clinical pathology.

[Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].

Y. Najean, O. Poirier, J. Arrago, 1984, Presse medicale.

Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long‐term follow‐up

M. Daniel, Y. Najean, C. Dresch, 1988, Cancer.

Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy.

R. Zittoun, G. Andreu, B. Rio, 1986, Blood.

Diagnostic value of bone marrow imaging with 111indium‐transferring and 99mtechnetium‐colloids in myelofibrosis

C. Chomienne, Y. Najean, N. Vigneron, 1985, American journal of hematology.

Clinical significance of serum pro‐collagen III in chronic myeloproliferative disorders

Y. Najean, O. Poirier, J. Arrago, 1990, European journal of haematology.

Type III aminoterminal propeptide of procollagen in some haematological malignancies.

C. Chomienne, Y. Najean, O. Poirier, 2009, Scandinavian journal of haematology.

The ‘spent’phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis

Y. Najean, C. Dresch, J. Rain, 1984, British journal of haematology.

[Gougerot-Sjögren syndrome. Functional study of the salivary glands by scintigraphy].

F. Rocher, A. Pecking, Y. Najean, 1984, Presse medicale.

111 Indium labelling of red cells: its clinical use in haemolytic anaemias.

Y. Pommier, Y. Najean, F. Deschrywer, 1986, Journal of clinical pathology.

N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.

F. Bauduer, R. Zittoun, B. Rio, 1993, Bone marrow transplantation.